Abstract:Background: The effect of pharmacological treatment of gastric cancer (GC) is limited, thus, it holds significant scientific importance to thoroughly investigate the molecular mechanisms underlying GC development and identify novel molecules capable of substantially extending patients' survival. This study utilized bioinformatics techniques to identify 11 genes associated with recurrence-free survival (RFS) in GC patients and investigated the potential biological functions of these genes through single-cell transcriptomic analysis. Subsequently, a single gene Cystatin A (CSTA) was selected for further analysis to explore its impact on signaling pathways and treatment. Methods: Differentially expressed genes (DEGs) were identified and overlapped in the analysis of RFS to identify potential prognostic genes for GC patients, based on data from the Cancer Genome Atlas-stomach adenocarcinoma (TCGA-STAD) and GSE54129. Subsequently, a prognostic model based on RFS in GC patients was established. Single-cell sequencing data were employed to explore the potential functions of these model genes. CSTA, one of the RFS-related genes, was further investigated using immunohistochemistry (IHC), Cell Counting Kit 8 (CCK-8), transwell, scratch, colony formation assays, flow cytometry, and Western blotting methods. Results: Through bioinformatics analysis, we identified 23 RFS-related genes in GC. Using the least absolute shrinkage and selection operator (LASSO)-Cox method, an RFS prognostic model was developed which pinpointed 11 GC prognosis-related (GPR) genes as significant factors influencing RFS in GC patients. The single-cell analysis revealed their potential role in affecting differentiation and maturation of pre-fibroblasts thereby impacting RFS in GC patients. CSTA exhibited low expression levels in GC tissues. Overexpression of CSTA promoted apoptosis in GC cells through the caspase-dependent apoptotic pathway and enhanced their response to cisplatin via this same pathway. Conclusions: The 11 GPR genes are primarily enriched within a specific type of stromal cell exhibiting heightened communication, metabolism, and differentiation levels. The gene signature of these stromal cells has implications for patient prognosis. Additionally, CSTA, a gene related to prognosis, has been shown to influence apoptosis levels in GC cells.

DACT1 is Silenced by CpG Methylation in Gastric Cancer and Contributes to the Pathogenesis of Gastric Cancer

Epigenetic Inactivation of BCL6B, a Functional Tumor Suppressor for Gastric Cancer, is Associated with Poor Survival of Gastric Cancer

Quantitative Proteomics Analysis of the Role of Tetraspanin-8 in the Drug Resistance of Gastric Cancer.

The Keratin 17/YAP/IL6 Axis Contributes to E-cadherin Loss and Aggressiveness of Diffuse Gastric Cancer

Dapper Homolog 1 is a Novel Tumor Suppressor in Gastric Cancer Through Inhibiting the Nuclear Factor-κB Signaling Pathway

Protocadherin 17 Acts As a Tumour Suppressor Inducing Tumour Cell Apoptosis and Autophagy, and is Frequently Methylated in Gastric and Colorectal Cancers

DACT2 is Frequently Methylated in Human Gastric Cancer and Methylation of DACT2 Activated Wnt Signaling.

DACT2 Silencing by Promoter CpG Methylation Disrupts Its Regulation of Epithelial-to-mesenchymal Transition and Cytoskeleton Reorganization in Breast Cancer Cells.

Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth

Gastric Tumor-Initiating CD44+ Cells and Epithelial-Mesenchymal Transition Are Inhibited by Γ-Secretase Inhibitor DAPT

CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization

Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.

942 Epigenetic Silencing of DACH1 Induces the Invasion and Migration of Gastric Cancer by Activating TGF-β Signaling

Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway

Paracrinal Hedgehog Signaling Activates Pancreatic Stellate Cell by Regulating Metabolism in Pancreatic Cancer

Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts

ITGA5 Inhibition in Pancreatic Stellate Cells Re-Educates the in Vitro Tumor-Stromal Crosstalk

Altered Expression of PTCH and HHIP in Gastric Cancer Through Their Gene Promoter Methylation: Novel Targets for Gastric Cancer

Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer

Circ-0075305 hinders gastric cancer stem cells by indirectly disrupting TCF4–β-catenin complex and downregulation of SOX9

Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target